CIC nanoGUNE BRTA, San Sebastian, Spain.
Servicio de Genética, Hospital Universitario Ramón y Cajal, IRYCIS and Centro de Investigaciones Biomédicas en Red de Enfermedades Raras, Madrid, Spain.
Nat Microbiol. 2023 Jan;8(1):77-90. doi: 10.1038/s41564-022-01265-y. Epub 2023 Jan 2.
Clustered regularly interspaced short palindromic repeats (CRISPR)-associated Cas9 is an effector protein that targets invading DNA and plays a major role in the prokaryotic adaptive immune system. Although Streptococcus pyogenes CRISPR-Cas9 has been widely studied and repurposed for applications including genome editing, its origin and evolution are poorly understood. Here, we investigate the evolution of Cas9 from resurrected ancient nucleases (anCas) in extinct firmicutes species that last lived 2.6 billion years before the present. We demonstrate that these ancient forms were much more flexible in their guide RNA and protospacer-adjacent motif requirements compared with modern-day Cas9 enzymes. Furthermore, anCas portrays a gradual palaeoenzymatic adaptation from nickase to double-strand break activity, exhibits high levels of activity with both single-stranded DNA and single-stranded RNA targets and is capable of editing activity in human cells. Prediction and characterization of anCas with a resurrected protein approach uncovers an evolutionary trajectory leading to functionally flexible ancient enzymes.
成簇规律间隔短回文重复序列 (CRISPR)-相关的 Cas9 是一种效应蛋白,可靶向入侵的 DNA,并在原核适应性免疫系统中发挥主要作用。尽管化脓性链球菌 CRISPR-Cas9 已被广泛研究并重新用于包括基因组编辑在内的应用,但它的起源和进化仍知之甚少。在这里,我们研究了来自现已灭绝的厚壁菌门物种中复活的古代核酶 (anCas) 的 Cas9 的进化,这些物种在距今 26 亿年前就已经灭绝。我们证明,与现代 Cas9 酶相比,这些古老的形式在其向导 RNA 和间隔区相邻基序要求方面更加灵活。此外,anCas 表现出从尼克酶到双链断裂活性的逐渐古酶适应,对单链 DNA 和单链 RNA 靶标具有很高的活性,并且能够在人类细胞中进行编辑活性。通过复活蛋白的方法对 anCas 进行预测和表征,揭示了一种导致功能灵活的古老酶的进化轨迹。